Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Biocartis forum geopend
Volgen
Ik ben vrij zeker dat we zonder de brand in augustus hoger hadden gestaan, omdat we nog niet weten wat de impact gaat zijn op de jaarprestaties. Voor het zelfde geld pakken die veel beter uit dan ze nu laten uitschijnen. Maar dan is er natuurlijk 2022, wat zijn de vooruitzichten voor volgend jaar om eindelijk naar winstgevendheid te gaan.. met of zonder extra financiering, that is the question.
Klopt als een bus ElTorro. Voor het eerst (hopelijk/normaal) meer dan 100k cartridges op een kwartaal (hopelijk al een stukje er boven). Zouden er al cartridges met ImmunExpress verkocht worden dit kwartaal? Hoeveel zouden er daarvan op jaarbasis realistisch gezien verkocht kunnen worden?
Thole, altijd wordt er nog gepraat over de brand,waar ze hun"voorraad"? hebben zien fikken! Ergens moeten er toch maandelijkse leveringen zijn? Hoe kan je spreken over groei wanneer je niet aan je basis producten geraakt?Nog zo iets wat op de koers weegt.
Klopt dat ze deel van hun basisproducten verloren zijn, maar in veel industrieën (of toch deze die mij bekend zijn) zijn de spanningen omtrend leveringen en dergelijke de laatste maand toch ferm gestabiliseerd en al stuk afgenomen. Bovendien als je groei inplant, plan je ook je toekomstige aankopen al stuk op voorhand een stuk hoger in. Dat wil zeggen grotere leveringen in oktober-november-december. 100k cartridges is niet zoveel meer vergeleken met q3 van dit jaar he. Dat is maar 10% +-.
CGCDLR, Kun je die KO nog eens toelichten waar je het over had. Gaat dit over de converteerbare schulden in de balans?
ElTorro, volgens mij gaan ze nog een nieuwe kapitaal operatie nodig hebben.Eind 2021 zou hun cashpositie nog 50 milj € bedragen.2022 gaat er groei zijn,of die groot genoeg is om zwarte cijfers te schrijven is maar de vraag.Wanneer er forse groei is zal er ook aan een derde lijn moeten komen.
finance.yahoo.com/news/exact-sciences... So Exas is touting the use of Ocotype Dx radiation benefit score in a new study/presentation. My question is what is their European plan now that they ended the Idylla IVD version of the test. Do they have a European lab or a partnership to provide the testing services? Years ago GHDX said European laws would not allow sending biopsy samples back to the USA. Anyone have insights to how they are rolling out in the EU? FL
Other reads on your subject via (see link next post). Couldn't find anything on European partnerships however.
(https://investor.exactsciences.com/investor-relations/press-releases/default.aspx)
A few months ago, I indicated that the best option for raising cash was an offering on the Nasdaq. Well the valuations of MDx companies has come way down, so it is not as attractive as when I first mentioned the idea early in the year. Perhaps they can offer shares of Wondfocartis on the China exchanges. Just joking. FL
FL, ergens gaan ze wel geld vinden,liever vroeg dan laat!
A suggestion for BCART Management.beursig.com/forum/viewtopic.php?f=6&a... The current PCR reagents used in Idylla are generated through a Freeze Dry operation so that they meet shelf stable storage requirements. There are very limited number of suppliers for the dried PCR reagents. Merk is evaluating Enwave's Drying technology for use in drying vaccines so that they might have greater stability and potential for usage throughout the world. BCART should evaluate the use of Enwave's REV technology for its PCR reagents. If a bench scale test shows that PCR reagents can be successfully dried using this process it would accomplish two goals: 1) it would give BCART negotiating clout with existing suppliers by demonstrating that they have alternatives available; 2) It might help shore up the supply chain for their product since their are many more suppliers of wet PCR reagents. Just a thought. Considerable analysis would be required to verify that the enzymes maintain potency through the drying process and that they are a suitable replacement. FL
Hiring seems to continue and even accelerate: 7 new vacancies in the last 2 days Indication of activities speeding up again ?
Tomtesteron Omicron should set a fantastic environment for Idylla since it has a long shelf life and requires little lab hands on time. However, as we have discussed, the availability of dried PCR reagents may limit the supply that can be turned out. Question for those in Belgium familiar with the transparency disclosure notification requirements. If reagent availability becomes limited such that BCART cannot meet demand despite plenty of orders, are they required to provide transparency notification to investors if they will fall short or miss their guidance numbers? I think in the U.S. this would be a material event that would require notification. FL
A little more color on my concerns over BCARTs Supply lines. twitter.com/jcbarret/status/147113691... FL
New hiring not always means an increase in the workforce, it might simply be a high turnover, which would be a bad sign.
Enwave has a pharma and food drying or "lyophilization" partnership agreement with GEA in Germany. If initial testing in vaccines and monoclonal antibodies has been encouraging, I think it is worth evaluating for PCR reagents. The current Omicron wave of Covid is going to place a strain on reagent availability. If they can make the supply chain more flexible it will have been worth the effort. The following statement is from today's earnings enouncement. FL "Advanced the development of using REV™ in the pharmaceutical sector through a material transfer agreement with AstraZeneca AB (NASDAQ:AZN) to dry monoclonal antibodies and completed the installation of a pilot-scale pharmaceutical REV™ machine with GEA Lyophil GmbH (“GEA”). EnWave has a joint development agreement with GEA in place to advance the design and application of microwave-assisted lyophilization for pharmaceutical applications, and the pilot-scale machine will be used to conduct demonstrations for interested pharmaceutical companies. GEA has several leading global pharmaceutical companies confirmed to trial REV™ in 2022."
COVID-19: Doubling time of Omicron could make PCR testing 'meaningless' - is it time for a rethink?news.sky.com/story/covid-19-doubling-... This is probably old news for Europeans but a trypical 48 hr TAT on PCR results is not going to cut it for Omicron. Idylla, Cepheid and other fast tests are well positioned since they provide accurate results quickly. Hopefully this is the final wave of this virus. I'm also hopefull that while Omnicron is the most transmissive virus I could have imagined, so far it looks like it primarily results in a more mild case. It makes you wonder whether the common cold coronavirus emerged eons ago in the same way and then mutated to less deadly forms over time. Have a good weekend. FL
Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Testjournals.asm.org/doi/10.1128/Spectrum...
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Premium
Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!
Word abonnee